| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Carmen Lorena Robaina Cabrera, Sandra Keir-Rudman, Nick Horniman, Nick Clarkson, Clive Pag. The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination. Pulmonary pharmacology & therapeutics. vol 69. 2021-10-21. PMID:34082108. |
studies with cannabis sativa plant extracts and endogenous agonists of cannabinoid receptors have demonstrated anti-inflammatory, bronchodilator, and antitussive properties in the airways of allergic and non-allergic animals. |
2021-10-21 |
2023-08-13 |
Not clear |
| Carmen Lorena Robaina Cabrera, Sandra Keir-Rudman, Nick Horniman, Nick Clarkson, Clive Pag. The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination. Pulmonary pharmacology & therapeutics. vol 69. 2021-10-21. PMID:34082108. |
however, the potential therapeutic use of cannabis and cannabinoids for the treatment of respiratory diseases has not been widely investigated, in part because of local irritation of airways by needing to smoke the cannabis, poor bioavailability when administered orally due to the lipophilic nature of cannabinoids, and the psychoactive effects of Δ9-tetrahydrocannabinol (Δ9-thc) found in cannabis. |
2021-10-21 |
2023-08-13 |
Not clear |
| Carmen Lorena Robaina Cabrera, Sandra Keir-Rudman, Nick Horniman, Nick Clarkson, Clive Pag. The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination. Pulmonary pharmacology & therapeutics. vol 69. 2021-10-21. PMID:34082108. |
the primary purpose of this study was to investigate the anti-inflammatory effects of two of the non-psychotropic cannabinoids, cannabidiol (cbd) and cannabigerol (cbg) alone and in combination, in a model of pulmonary inflammation induced by bacterial lipopolysaccharide (lps). |
2021-10-21 |
2023-08-13 |
Not clear |
| Gi Liou, Ab El-Remessy, As Ibrahim, Rb Caldwell, Ym Khalifa, A Gunes, Jj Nussbau. Cannabidiol As a Putative Novel Therapy for Diabetic Retinopathy: A Postulated Mechanism of Action as an Entry Point for Biomarker-Guided Clinical Development. Current pharmacogenomics and personalized medicine. vol 7. issue 3. 2021-10-20. PMID:20953236. |
this review is focused on cannabidiol, a non-psychoactive native cannabinoid, as an emerging and novel therapeutic modality based on systematic studies in animal models of inflammatory retinal diseases including diabetic retinopathy - one of the retinal diseases associated with vascular neuroinflammation. |
2021-10-20 |
2023-08-12 |
Not clear |
| Philip R Cohe. Therapeutic and Cosmetic Uses of Cannabis: Cannabinoids for Acne Treatment and Skin -Rejuvenation. Skinmed. vol 19. issue 1. 2021-10-19. PMID:33658112. |
therapeutic and cosmetic uses of cannabis: cannabinoids for acne treatment and skin -rejuvenation. |
2021-10-19 |
2023-08-13 |
Not clear |
| Jessica Rice, Andrea Hildebrand, Rebecca Spain, Angela Senders, Elizabeth Silbermann, Lindsey Wooliscroft, Vijayshree Yadav, Dennis Bourdette, Michelle Camero. A cross-sectional survey of cannabis use by people with MS in Oregon and Southwest Washington. Multiple sclerosis and related disorders. vol 55. 2021-10-19. PMID:34332457. |
evidence supports that cannabinoids reduce self-reported spasticity and neuropathic pain in people with ms (pwms), and legal access to cannabis for medical and recreational use continues to rise. |
2021-10-19 |
2023-08-13 |
Not clear |
| Bao Xue, Xia Zhang, Ying Wan. Bench to bedside: Multiple facets of cannabinoid control in epilepsy. Neurochemistry international. vol 141. 2021-10-18. PMID:33159980. |
further in clinic, cannabidiol as an add-on treatment could reduce seizures in patients with treatment-resistant epilepsy, but the underlying mechanisms are still unclear and independent of the endocannabinoid system. |
2021-10-18 |
2023-08-13 |
Not clear |
| Anees Bahj. Response to Canadian Psychiatric Association Cannabinoid Products Position Statement: Potential for Ameliorating Cannabis Withdrawal. Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 66. issue 6. 2021-10-18. PMID:33998318. |
response to canadian psychiatric association cannabinoid products position statement: potential for ameliorating cannabis withdrawal. |
2021-10-18 |
2023-08-13 |
Not clear |
| Martyna Hordowicz, Jerzy Jarosz, Małgorzata Czaplińska, Agnieszka Leonhard, Anna Klimkiewic. Polish Physicians' Perspectives on Medical Cannabis Policy and Educational Needs: Results of An Online Survey. Journal of clinical medicine. vol 10. issue 19. 2021-10-16. PMID:34640561. |
furthermore, 71.7% believed that medicines containing cannabinoids and 52.0% that herbal cannabis should be reimbursed (3). |
2021-10-16 |
2023-08-13 |
human |
| Sirichai Chayasirisobho. Mechanisms of Action and Pharmacokinetics of Cannabis. The Permanente journal. vol 25. 2021-10-15. PMID:33635755. |
at least 100 cannabis species are compounds known as cannabinoids, a molecule with a 21-carbon terpenophenolic skeleton. |
2021-10-15 |
2023-08-13 |
Not clear |
| Sirichai Chayasirisobho. Mechanisms of Action and Pharmacokinetics of Cannabis. The Permanente journal. vol 25. 2021-10-15. PMID:33635755. |
cannabinoids produce more than 100 naturally occurring chemicals, the most abundant of which are Δ-9-tetrahydrocannabinol (thc), cannabidiol (cbd), terpenes, and flavonoids. |
2021-10-15 |
2023-08-13 |
Not clear |
| Sirichai Chayasirisobho. The Role of Cannabidiol in Neurological Disorders. The Permanente journal. vol 25. 2021-10-15. PMID:33970090. |
cannabinoids are compounds in cannabis that are known to have therapeutic potential. |
2021-10-15 |
2023-08-13 |
Not clear |
| Sirichai Chayasirisobho. The Role of Cannabidiol in Neurological Disorders. The Permanente journal. vol 25. 2021-10-15. PMID:33970090. |
the most abundant chemicals in cannabinoids are delta-9-tetrahydrocannabinol and cannabidiol. |
2021-10-15 |
2023-08-13 |
Not clear |
| Catherine F Moore, Elise M Weert. Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations. Psychopharmacology. 2021-10-15. PMID:34652500. |
cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (thc) and cannabidiol (cbd) in male and female rats: sex, dose-effects and time course evaluations. |
2021-10-15 |
2023-08-13 |
rat |
| Matheus Perez, Luciana Politti Cartarozzi, Gabriela Bortolança Chiarotto, Francisco Silveira Guimarães, Alexandre Leite Rodrigues de Oliveir. Short and long-term neuroprotective effects of cannabidiol after neonatal peripheral nerve axotomy. Neuropharmacology. vol 197. 2021-10-14. PMID:34303725. |
the present study aimed to investigate the neuroprotective potential of cannabidiol (cbd) and the role of cannabinoid receptors after sciatic nerve crush in neonatal rats. |
2021-10-14 |
2023-08-13 |
rat |
| Luis Vitetta, Belinda Butcher, Jeremy D Henson, David Rutolo, Sean Hal. A pilot safety, tolerability and pharmacokinetic study of an oro-buccal administered cannabidiol-dominant anti-inflammatory formulation in healthy individuals: a randomized placebo-controlled single-blinded study. Inflammopharmacology. vol 29. issue 5. 2021-10-14. PMID:34357480. |
the cannabis plant presents a complex biochemical unit of over 500 constituents of which 70 or more molecules have been classified as cannabinoids binding to cannabinoid receptors. |
2021-10-14 |
2023-08-13 |
Not clear |
| F Mitchell Westmoreland, Paul Kusuma, Bruce Bugbe. Cannabis lighting: Decreasing blue photon fraction increases yield but efficacy is more important for cost effective production of cannabinoids. PloS one. vol 16. issue 3. 2021-10-13. PMID:33755709. |
cannabis lighting: decreasing blue photon fraction increases yield but efficacy is more important for cost effective production of cannabinoids. |
2021-10-13 |
2023-08-13 |
Not clear |
| Virginia Brighenti, Lucia Marchetti, Lisa Anceschi, Michele Protti, Patrizia Verri, Federica Pollastro, Laura Mercolini, Davide Bertelli, Chiara Zanardi, Federica Pellat. Separation and non-separation methods for the analysis of cannabinoids in Cannabis sativa L. Journal of pharmaceutical and biomedical analysis. vol 206. 2021-10-13. PMID:34537622. |
separation and non-separation methods for the analysis of cannabinoids in cannabis sativa l. cannabis sativa l. is a plant known all over the world, due to its history, bioactivity and also social impact. |
2021-10-13 |
2023-08-13 |
Not clear |
| Theodore J Wite. Please don't call it medical marijuana unless it is; but it probably isn't. Canadian journal of public health = Revue canadienne de sante publique. vol 112. issue 1. 2021-10-12. PMID:32557287. |
to distill the potential medical benefits through the pharmacologic understanding of the endocannabinoid system, cannabis should follow the traditional drug development process or one that improves upon it. |
2021-10-12 |
2023-08-13 |
Not clear |
| Antonio Franco-Vadillo, Mireille Toledo-Blass, Zeltzin Rivera-Herrera, Gustavo Guevara-Balcazar, Oscar Orihuela-Rodriguez, Jose A Morales-Carmona, Alexandre Kormanovski-Kovzova, Pedro Lopez-Sanchez, Ivan Rubio-Gayosso, Maria Del Carmen Castillo-Hernande. Cannabidiol-mediated RISK PI3K/AKT and MAPK/ERK pathways decreasing reperfusion myocardial damage. Pharmacology research & perspectives. vol 9. issue 4. 2021-10-12. PMID:34176244. |
there are many cardioprotective agents; within these, cannabinoids have shown to have beneficial effects, mainly cannabidiol (cbd). |
2021-10-12 |
2023-08-13 |
rat |